Consequently, we cannot further explore the hypothesis that variations in oxytocin use during labour and in first-line PPH management may play a role in differences in PPH severity and, as a consequence, in maternal mortality ratio due to PPH between the two countries. The gene discussed is OXT; the disease is pulmonary arterial hypertension.